Statins for Prevention in Non-High Risk Patients
2016 saw the publication of the latest large randomised trial investigating the role of cholesterol lowering drugs known as Statins in preventing adverse cardiovascular events. The HOPE trial(1) investigated the effect of a low dose statin and a blood-pressure-reducing medication (candesartan/hydrochlorothiazide) on the incidence of cardiovascular events compared with placebo, in men ≥55years and women ≥65years [...]